Issue #1 2015 – Digital edition
Posted: 10 March 2015 | European Pharmaceutical Review
In Issue #1 2015: Regulatory Insight, Biologics, NIR in-depth focus, Raman in-depth focus, PAT, Drug Delivery, Microbiology Series and much more…
- Regulatory Insight: Turkey – A rising star in the pharmaceutical industry
Özge Atılgan Karakulak and Zeynep Koray (Gün + Partners) - Biologics: TandAbs – potent and well-manufacturable bi-specific antibodies
Michael Weichel, Kristina Ellwanger, Ivica Fucek, Stefan H.J. Knackmuss, Erich Rajkovic, Uwe Reusch, Claudia Wall, and Eugene A. Zhukovsky (Affimed Therapeutics AG) - In-depth focus: NIR
Featuring articles from Emil W. Ciurczak (Doramaxx Consulting), Manel Bautista Mercader (Kymos Pharma Services) and Jose Manuel Amigo Rubio (University of Copenhagen). Manel Bautista Mercader also moderates a NIR Roundtable… - In-depth focus: Raman
Featuring articles from Anna Łuczak (Bristol-Myers Squibb), Zafar Iqbal (New Jersey Institute of Technology) and Nikolaos Scoutaris (University of Greenwich). A Roundtable on Raman is moderated by Emil W. Ciurczak (Doramaxx Consulting)… - PAT: Continued process verification – a challenge for the pharmaceutical industry?
Michael Rommerskirchen (Boehringer Ingelheim) - Drug Delivery Series: Evaluating inhaler performance using idealised throats
Andrew R. Martin and Warren H. Finlay (University of Alberta) - Microbiology Series: The role of water activity in the microbial stability of non-sterile drug products
Tony Cundell (Consulting Microbiologist, Scarsdale)
The digital version of Issue #1 2015 is restricted - login or subscribe free to access
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here